| Current Price | $37.33 | Mkt Cap | $5.6B |
|---|---|---|---|
| Open | $39.36 | P/E Ratio | 0.00 |
| Prev. Close | $39.89 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $36.03 - $39.58 | Volume | 4,030,582 |
| 52-Wk Range | $36.03 - $64.37 | Avg. Daily Vol. | 1,614,472 |
The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.
| Current Price | $37.33 | Mkt Cap | $5.6B |
|---|---|---|---|
| Open | $39.36 | P/E Ratio | 0.00 |
| Prev. Close | $39.89 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $36.03 - $39.58 | Volume | 4,030,582 |
| 52-Wk Range | $36.03 - $64.37 | Avg. Daily Vol. | 1,614,472 |
The best Bull and Bear pitches based on recency and number of recommendations.
They have a new anticoagulant which in 300 humans, given preoperatively for knee replacement, yielded NO clots (as opposed to 15% for Lovenox) and a bleeding risk of 5%, compared to 8% for Lovenox. This is a game-changer.
Read the most recent pitches from players about IONS.
Recs
TMFacarchidi
(< 20)
Submitted: 3/1/2021 11:32:39 AM :
Start Price:
$54.28
NASDAQ:IONS Score:
-38.94
Niche portfolio of drugs, with rare disease-targeted pipeline projects approaching completion.
Recs
MKWas
(< 20)
Submitted: 2/18/2021 3:01:53 PM :
Start Price:
$57.84
NASDAQ:IONS Score:
-42.60
A leaders in antisense oligonucleotides, an emerging technology used to control messenger RNA .
Recs
IndyAnthony
(41.87)
Submitted: 2/5/2021 11:57:00 PM :
Start Price:
$60.59
NASDAQ:IONS Score:
+46.04
This biotech pharma company has out performed the S&P 500 over the last 10 years by hundreds of percent, but over the last 5 years, IONS has lost to the market by almost 30%, with most of those losses coming in 2020. The Founders are still involved, but institutions own almost 87% of the company. Despite collaborations with Roche, Biogen, and AstraZeneca, I think this company will underperform the market over the next 5-10 years.
Find the members with the highest scoring picks in IONS.
yosemitebean (36.27) Score: +619.58
The Score Leader is the player with the highest score across all their picks in IONS.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| RXDOC73 | 98.26 |
|
|
NS | $6.59 | +466.46% | +250.98% | +215.48 | 1 Comment | |
| uclajphil6 | < 20 | 1/7/2009 |
|
3W | $13.98 | +167.02% | +369.72% | +202.69 | 0 Comment | |
| Myshkin69 | < 20 | 11/14/2011 |
|
5Y | $6.99 | +434.05% | +233.97% | +200.08 | 0 Comment | |
| loangolfer | < 20 |
|
|
NS | $6.99 | +434.05% | +234.67% | +199.38 | 0 Comment | |
| Santa22 | < 20 | 9/22/2006 |
|
3Y | $7.02 | +431.77% | +238.89% | +192.87 | 0 Comment | |
| asterionc2 | 72.47 | 9/27/2006 |
|
5Y | $7.10 | +425.77% | +233.41% | +192.37 | 0 Comment | |
| jdmckeehan | < 20 | 10/2/2006 |
|
3Y | $7.18 | +419.92% | +233.15% | +186.76 | 0 Comment | |
| JerryDreamer | < 20 | 8/17/2009 |
|
3W | $15.37 | +142.88% | +325.98% | +183.11 | 1 Comment | |
| leadtip | < 20 | 8/25/2006 |
|
1Y | $7.09 | +426.52% | +244.78% | +181.73 | 0 Comment | |
| John8464 | < 20 | 9/15/2006 |
|
1Y | $7.23 | +416.32% | +235.10% | +181.22 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
